title: Reply to U. Ravnskov et al, D. Tural et al, and M.A.N. Şendur et al.
authors.affiliation: Queen's University Belfast, Belfast, United Kingdom c.cardwell@qub.ac.uk.
authors.forename: Chris R
authors.initials: CR
authors.lastname: Cardwell
authors.affiliation: Queen's University Belfast, Belfast, United Kingdom.
authors.forename: Blanaid M
authors.initials: BM
authors.lastname: Hicks
authors.affiliation: Queen's University Belfast, Belfast, United Kingdom.
authors.forename: Carmel
authors.initials: C
authors.lastname: Hughes
authors.affiliation: Queen's University Belfast, Belfast, United Kingdom.
authors.forename: Liam J
authors.initials: LJ
authors.lastname: Murray
mesh_terms: D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D011159:Population Surveillance / Q000379:methods*; D012042:Registries / Q000706:statistics & numerical data*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors